GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 63 days ( 0 % )
Last Price $2.23 0 %
High/ Low $2.23 - $2.23 0%
Chg 7 Days N/A $2.23 $2.23
Chg 30 Days N/A $2.23 $2.23
Chg 12 mos 17.37 % $1.90 $2.23
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 11.66 % Width: 88.03 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $1.80 - $3.38 -19.38 % - 51.59 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Buy 2023-09-19 - 64 days
Long MA avg 12 mos Buy 2023-06-05 - 137 days
Short/Long MA avg 12 mos Buy 2023-06-21 - 126 days
Pivot Short Sell 2023-12-18 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Paratek Pharmaceuticals

Paratek Pharmaceuticals Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia and acute ... PRTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT